The Trendlines Group

The Trendlines Group is an investment company that invents, discovers, invests in, and incubates innovation-based medical and agricultural technologies. It is involved in all aspects of its portfolio companies, from technology development to business building. The firm focuses on seed, start-up, and early-stage venture investments primarily in Israel and Singapore. Trendlines is publicly traded on the Singapore Stock Exchange (SGX: 42T) and in the U.S. on the OTCQX (OTCQX: TRNLY). In November 2022, the company announced a strategic shift to focus on developing its existing portfolio to maximize exit proceeds, temporarily suspending investments in new companies.